The Agency is reviewing its approach to how it engages and involves patients in its work and wants to adopt a more systematic approach to listening to and involving patients – ensuring that the patient voice is heard when safety issues, concerning medicines or medical devices, are identified and in the licensing of new medicines.
To inform the review, MHRA has launched a consultation on its patient and public engagement.
Please see the consultation page on the Agency’s website for further details, including a link to the online questionnaire and a downloadable version for those who would prefer to respond offline.
The consultation is open for 12 weeks and will close at 11.45pm on Monday 7th October 2019.
You are invited to attend a meeting, to be held on Tuesday 3 September, 12:00 – 13:30, at Welsh Government, Cathays Park, at which representatives from MHRA will provide background information about the consultation and will be seeking your views.
MHRA would particularly like to hear from patients, carers, patient groups and health sector charities.
This is an opportunity for you to meet the regulator and have your say!
Access to Medicines Policy Manager
Pharmacy and Prescribing Branch / Y Gangen Fferylliaeth a Rhagnodi
Welsh Government / Llywodraeth Cymru
Tel / Ffon 03000 255621
E-mail / E-bost [email protected]